Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Compare the flexibility of zero based budgeting with traditional budgets to understand tradeoffs and where each works best.
21,079 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Bitcoin miners start funding AI pivots by borrowing and selling BTC to stay liquid as margins tighten, hash prices fa...
BlackRock's tokenized BUIDL fund will publish continuous on-chain attestations to back holdings, valuation, and custo...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
HIMU sits vulnerable double risk as slower growth weighs on credits and persistent yields pressure long-duration muni...
Costco just posted strong Q2 FY26 results, fueling a bullish one-year outlook. This article breaks down the data, gro...
Bitcoin slid to about $79,679 as geopolitical tensions flare, but the week remains on track for a sixth straight week...
A newly launched AI agent is set to overhaul how builders screen land and gauge deal risk, potentially speeding loans...
A lesser-known chip stock is catching the AI wave’s spotlight. This article breaks down why it’s rallying, what fuels...
The VanEck PFXF ETF focuses on non-financial preferred securities, offering a ~6.7% yield. But investors must watch c...
Private investors gain access to 25,000+ multifamily units via Lightstone DIRECT as rents rise in low-supply markets,...
A new proposal aims to end blind signing in Ethereum wallets. The change could reduce scam losses and tighten securit...